During the past decade, Clinical Research Consortium conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 21 clinical trials were completed, i.e. on average, 84% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 14 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Consortium" #1 sponsor was "Pfizer" with 5 trials, followed by "AEON Biopharma, Inc." with 2 trials sponsored, "Seqirus" with 2 trials sponsored, "Sunovion" with 2 trials sponsored and "Sunovion Respiratory Development Inc." with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Consortium" #1 collaborator was "PPD" with 2 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Institut de Recherches Internationales Servier" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Consortium" are "Migraine" (3 trials), "COPD" (2 trials), "Migraine, With or Without Aura" (2 trials), "Osteoarthritis, Hip" (2 trials) and "Osteoarthritis, Knee" (2 trials). Many other conditions were trialed in "Clinical Research Consortium" in a lesser frequency.

Most popular intervention types in "Clinical Research Consortium" are "Drug" (21 trials), "Biological" (6 trials), "Device" (2 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "ABP-450" (2 trials), "Eslicarbazepine acetate" (2 trials), "Placebo Comparator" (2 trials) and "Rimegepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Consortium" are 29 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Research Consortium". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in Clinical Research Consortium, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Consortium, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".